JPH08512299A - 5ht▲下2c▼アンタゴニストとしてのインドリン誘導体 - Google Patents

5ht▲下2c▼アンタゴニストとしてのインドリン誘導体

Info

Publication number
JPH08512299A
JPH08512299A JP7503812A JP50381295A JPH08512299A JP H08512299 A JPH08512299 A JP H08512299A JP 7503812 A JP7503812 A JP 7503812A JP 50381295 A JP50381295 A JP 50381295A JP H08512299 A JPH08512299 A JP H08512299A
Authority
JP
Japan
Prior art keywords
indoline
pyridylcarbamoyl
chloro
methyl
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7503812A
Other languages
English (en)
Japanese (ja)
Inventor
ハム,ピーター
ジョーンズ,グレアム・エルジン
フォーブズ,イアン・トムソン
Original Assignee
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー filed Critical スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Publication of JPH08512299A publication Critical patent/JPH08512299A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Eyeglasses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP7503812A 1993-07-06 1994-06-30 5ht▲下2c▼アンタゴニストとしてのインドリン誘導体 Pending JPH08512299A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939313913A GB9313913D0 (en) 1993-07-06 1993-07-06 Novel compounds
GB9313913.7 1993-07-06
PCT/EP1994/002148 WO1995001976A1 (en) 1993-07-06 1994-06-30 Indoline derivatives as 5ht2c antagonists

Publications (1)

Publication Number Publication Date
JPH08512299A true JPH08512299A (ja) 1996-12-24

Family

ID=10738344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7503812A Pending JPH08512299A (ja) 1993-07-06 1994-06-30 5ht▲下2c▼アンタゴニストとしてのインドリン誘導体

Country Status (15)

Country Link
US (1) US5834494A (OSRAM)
EP (1) EP0707581B1 (OSRAM)
JP (1) JPH08512299A (OSRAM)
CN (1) CN1129937A (OSRAM)
AP (1) AP463A (OSRAM)
AT (1) ATE149163T1 (OSRAM)
AU (1) AU7228394A (OSRAM)
CA (1) CA2166624A1 (OSRAM)
DE (1) DE69401823T2 (OSRAM)
GB (1) GB9313913D0 (OSRAM)
IL (1) IL110204A0 (OSRAM)
MA (1) MA23254A1 (OSRAM)
TW (1) TW297023B (OSRAM)
WO (1) WO1995001976A1 (OSRAM)
ZA (1) ZA944807B (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
CN1151147C (zh) * 1995-02-02 2004-05-26 史密丝克莱恩比彻姆有限公司 作为5-ht受体拮抗剂的吲哚衍生物
WO1996023769A2 (en) * 1995-02-02 1996-08-08 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht2c receptor antagonist activity
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
CA2253941A1 (en) * 1996-05-16 1997-11-20 Sumanas Rakhit Thiophene- and furan-tryptamine derivatives
GB9612885D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612883D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
FR2778662B1 (fr) * 1998-05-12 2000-06-16 Adir Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU6123699A (en) * 1998-10-16 2000-05-08 Takeda Chemical Industries Ltd. Nitrogenous fused heterocycle compounds, process for the preparation thereof andagents containing the same
US6453357B1 (en) 1999-01-07 2002-09-17 Cisco Technology, Inc. Method and system for processing fragments and their out-of-order delivery during address translation
DK1178973T3 (da) * 1999-05-21 2006-05-08 Biovitrum Ab Pyrazinyl-piperazin-forbindelser, deres anvendelse og fremstilling
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
FR2810979B1 (fr) * 2000-06-29 2002-08-23 Adir Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
EP1278085B1 (en) * 2001-07-09 2003-05-21 Alcatel Connector for optical fibers
US6861440B2 (en) 2001-10-26 2005-03-01 Hoffmann-La Roche Inc. DPP IV inhibitors
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NZ536664A (en) 2002-06-19 2007-07-27 Biovitrum Ab Piperazinylpyrazine derivative compounds, their use and preparation
WO2005000846A1 (en) 2003-06-20 2005-01-06 F.Hoffmann-La Roche Ag Hexahydropyridoisoqinolines as dpp-iv inhibitors
MXPA05013904A (es) 2003-06-20 2006-02-24 Hoffmann La Roche Derivados de pirido[2,1-a] isoquinolinas como inhibidores de dipeptidil-peptidasa iv(dpp-iv).
EP1931622B1 (en) * 2005-09-13 2011-08-24 Bayer CropScience AG Phenyloxy substituted phenylamidine derivatives as pesticides
US8277650B2 (en) 2009-03-13 2012-10-02 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
CN106278987A (zh) * 2016-08-16 2017-01-04 都创(上海)医药科技有限公司 吲哚啉类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428881A (en) * 1977-12-23 1984-01-31 Gulf Oil Corporation Control of unwanted vegetation with N-carbamylindolines
US5328922A (en) * 1990-09-13 1994-07-12 Beecham Group P.L.C. Indole ureas as 5 ht receptor antagonist
EP0656003A1 (en) * 1992-08-20 1995-06-07 Smithkline Beecham Plc Condensed indole derivatives as 5ht2c and 5ht2b antagonists

Also Published As

Publication number Publication date
CA2166624A1 (en) 1995-01-19
DE69401823T2 (de) 1997-08-28
MA23254A1 (fr) 1995-04-01
US5834494A (en) 1998-11-10
AP463A (en) 1996-02-19
AU7228394A (en) 1995-02-06
DE69401823D1 (de) 1997-04-03
EP0707581B1 (en) 1997-02-26
AP9400653A0 (en) 1994-07-31
EP0707581A1 (en) 1996-04-24
CN1129937A (zh) 1996-08-28
TW297023B (OSRAM) 1997-02-01
ATE149163T1 (de) 1997-03-15
ZA944807B (en) 1996-01-04
GB9313913D0 (en) 1993-08-18
WO1995001976A1 (en) 1995-01-19
IL110204A0 (en) 1995-01-24

Similar Documents

Publication Publication Date Title
JPH08512299A (ja) 5ht▲下2c▼アンタゴニストとしてのインドリン誘導体
EP1278741B1 (en) Muscarinic agonists
EP0690843B1 (en) Formyl- or cyano- substituted indole derivatives having dopaminergic activity
JP2005527463A (ja) Cns疾患を治療するための5−ht6受容体アフィニティーを有する3−アリールスルホニル−7−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン
JPH07504429A (ja) 5HT↓1cアンタゴニストとしてのインドール誘導体
JPH08508289A (ja) 抗精神病ベンゾイミダゾール誘導体
JP2001526643A (ja) 5ht1a、5ht1bおよび5ht1d受容体アンタゴニスト活性を合わせ持つ化合物を含む二環式アリールまたは二環式複素環
AU6538294A (en) Indole derivatives as 5-ht1a and/or 5-ht2 ligands
JPH08511515A (ja) アセチルコリンエステラーゼの阻害剤としての1−置換イサチンおよびオキシンドール誘導体
JP3157179B2 (ja) 3−アリールカルボニル−1−アミノアルキル−1h−インドール含有抗緑内障組成物
KR100221158B1 (ko) 6-헤테로사이클릭-4-아미노-1,3,4,5-테트라하이드로벤즈(cd)인돌
HUP0002843A2 (hu) Új béta-karbolin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
JPH069618A (ja) ヒドロキシキノロン誘導体
JP2001521529A (ja) 置換へテロ芳香環5−ht▲下1f▼アゴニスト
JP2001512727A (ja) 5ht−1受容体のリガンドとしてのニ環式化合物
JP3174382B2 (ja) 6−複素環−4−アミノ−1,2,2a,3,4,5−ヘキサヒドロベンズ[cd]インドール類
JP2961023B2 (ja) 置換ピリジニルアミノ−1H−インドール、1H−インダゾール、2H−インダゾール、ベンゾ〔b〕チオフェンおよび1,2−ベンズイソチアゾール
HU203350B (en) Process for producing antiinflammatory tricyclic oxindole derivatives
JPH06211655A (ja) 乗物酔いおよび嘔吐症の処置用6−ヘテロ環−4−アミノ−1,3,4,5−テトラヒドロベンズ[cd]インドール類
JP2000508299A (ja) 抗ウイルス作用を有する置換キノリン誘導体
US8114899B2 (en) 2H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
JPH09512025A (ja) 5ht▲下2c▼および5ht▲下2b▼アンタゴニストとしての三環式誘導体
JP2000512306A (ja) 5―ht―2c受容体アンタゴニストとして有用なインドリン誘導体
JP2003518112A (ja) 置換型ピロール
JP2001526674A (ja) 5ht2c受容体アンタゴニストとしてのインドリン誘導体